Opella Healthcare Group

Opella is a global leader in the consumer healthcare industry, operating as a standalone business unit within Sanofi. The company maintains a vast portfolio of iconic over-the-counter brands, including Allegra, Doliprane, Dulcolax, Enterogermina, and Icy Hot. Opella focuses on five primary therapeutic areas: allergy, digestive wellness, pain care, physical and mental wellness, and cough, cold, and flu. With a presence in over 100 countries and a workforce of approximately 11,000 employees, it is one of the largest pure-play consumer health entities in the world. In late 2024, Sanofi entered into exclusive negotiations to sell a 50% controlling stake in Opella to the private equity firm Clayton, Dubilier & Rice (CD&R).